See what members are saying about AMD treatments, the side effects to expect, and the drug basics.
All treatment information is medically reviewed · July 1, 2025
Overview
Syfovre is approved by the U.S. Food and Drug Administration (FDA) for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). Syfovre is also known by its drug name…
Overview
Vabysmo is approved by the U.S. Food and Drug Administration (FDA) for the treatment of neovascular (wet) age-related macular degeneration (AMD). It’s prescribed for people who’ve developed abnormal blood vessels…
Overview
Yesafili is approved by the U.S. Food and Drug Administration (FDA) for the treatment of neovascular (wet) age-related macular degeneration (AMD), as well as macular edema following retinal vein occlusion…
Become a member to get even more